Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens

BACKGROUND: Gemcitabine plus cisplatin (GP) is a novel regimen of induction chemotherapy (IC) for treating locoregional advanced nasopharyngeal cancer (NPC). This retrospective study aimed to compare the efficacy of GP and TP (paclitaxel plus cisplatin) regimens in tumor volume reduction after IC. M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Zheng, Li, Liao, Wenjun, Xu, Peng, Li, Baisen, Wen, Hao, Zhang, Shichuan
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2018
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237045/
https://ncbi.nlm.nih.gov/pubmed/30406770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.909736
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars